incompatibility.docx

3
Nepsy C. Ucag, PH IV – B 8-5-15 Physical Incompatibility has been defined as a physical or chemical interaction between two or more ingredients which lead to a visibly recognizable change in the form of a gross precipitate, haze, or color change. (source: Compiled Lecture Notes for Pharmaceutical Chemistry 3A (Drug Quality Control 1) Examples: 1. Some dosage-form incompatibilities may be the result of unwanted complexation reactions. For example, some widely used polyethers (Tweens, Carbowaxes, or PEGs) can form precipitates with H-bond donors such as phenols and carboxylic acids. (Remington 21st Edition) 2. Physical incompatibilities frequently can be predicted by knowing the chemical characteristics of the drugs involved. For example, the sodium salts of weak acids, such as phenytoin sodium or phenobarbital sodium, precipitate as free acids when added to intravenous fluids with an acidic pH. (Remington 21st Edition) 3. Calcium salts precipitate when added to an alkaline medium. Injections that require a special diluent for solubilization, such as diazepam, precipitate when added to aqueous solutions because of their low water solubility. (Remington 21st Edition) Chemical incompatibility is classified as a reaction in which a visible changes does not occur. Since there is no visible evidence of deterioration, this type of incompatibility requires trained, knowledgeable personnel to recognize it, should it occur. (source: Compiled Lecture Notes for Pharmaceutical Chemistry 3A (Drug Quality Control 1) Examples: 1. Certain chemical incompatibilities have been reported in which the filler interfered with the bioavailability of the drug as in the case of calcium phosphate and tetracycline [40] and the reaction of certain amine bases with lactose in the presence of magnesium stearate.

Upload: nepsy-ucag

Post on 16-Aug-2015

334 views

Category:

Documents


2 download

TRANSCRIPT

Nepsy C. Ucag, PH IV B8-5-15Physical Incompatibility has been defned as a physical o che!ical in"eac"ion be"#een "#o o !oe ingedien"s #hich lead "o a $isibly ecogni%able change in "he&o! o& a goss pecipi"a"e, ha%e, o colo change. 'so(ce) Co!piled *ec"(e No"es&o Pha!ace("ical Che!is"y +, '-(g .(ali"y Con"ol 1/01a!ples) 1. 2o!e dosage-&o! incompatibilities !ay be "he es(l" o& (n#an"ed co!ple1a"ion eac"ions. 3o e1a!ple, so!e #idely (sed polye"hes '4#eens, Cabo#a1es, o P05s/ can &o! pecipi"a"es#i"h H-bond donos s(ch as phenols and cabo1ylic acids. '6e!ing"on 71s"0di"ion/7. Physical inco!pa"ibili"ies &e8(en"ly can be pedic"ed by 9no#ing "he che!ical chaac"eis"ics o& "he d(gs in$ol$ed. 3o e1a!ple, "he sodi(! sal"s o& #ea9 acids, s(ch as pheny"oin sodi(! o phenobabi"al sodi(!, pecipi"a"e as &ee acids #hen added "o in"a$eno(s :(ids #i"h an acidic pH.'6e!ing"on 71s"0di"ion/+. Calci(! sal"s pecipi"a"e #hen added "o an al9aline !edi(!. In;ec"ions "ha" e8(ie a special dil(en" &o sol(bili%a"ion, s(ch as dia%epa!, pecipi"a"e #hen added "o a8(eo(s sol("ions beca(se o& "hei lo# #a"e sol(bili"y. '6e!ing"on 71s"0di"ion/Chemical incompatibility is classifed as a eac"ion in #hich a $isible changes does no" occ(.2ince "hee is no $isible e$idence o& de"eioa"ion, "his "ype o& inco!pa"ibili"y e8(ies "ained, 9no#ledgeable pesonnel "o ecogni%e i", sho(ld i" occ(. 'so(ce) Co!piled *ec"(e No"es &o Pha!ace("ical Che!is"y +, '-(g .(ali"y Con"ol 1/ 01a!ples)1. Ce"ain che!ical inco!pa"ibili"ies ha$e been epo"ed in #hich "he flle in"e&eed #i"h "he bioa$ailabili"y o& "he d(g as in "he case o& calci(! phospha"e and "e"acycline ? and "he eac"ion o& ce"ain a!ine bases #i"h lac"ose in "he pesence o& !agnesi(! s"eaa"e. '*iebe!ann, *ach!an and 2ch#a"%, Pha!ace("ical -osage 3o!s 4able"s, Vol. 1/7. 4he eady ed(cibili"y o& sil$e ion "o ele!en"al sil$e gi$es ise "o $aio(s ins"abili"y poble!s and inco!pa"ibili"ies. Beca(se sil$e co!po(nds ae ligh" sensi"i$e, "hey !(s" be po"ec"edby "he (se o& ligh"-esis"an" con"aines. 4he sol(ble sil$e sal"s ae "o1ic. Ho#e$e, "he "o1ici"y (s(ally is li!i"ed, o#ing "o local pecipi"a"ion o& adheen" layes o& sil$e po"ein and sil$e chloide. '6e!ing"on 71s"0di"ion/Nepsy C. Ucag, PH IV B8-5-15+. Peo1ide i!p(i"ies in poly!es !ay ca"aly%e o1ida"i$e degada"ion eac"ions #i"h d(gs, incl(ding po"eins, "ha" ae o1ygen sensi"i$e. '6e!ing"on 71s"0di"ion/Therapeutic incompatibility has been defned as an (ndesiable pha!acological in"eac"ion be"#een "#o o !oe ingedien"s #hich lead "o 1. po"en"ia"ion o& "he "heape("ic e@ec"s o& "he ingedien"s, 7. des"(c"ion o& "he e@ec"i$eness o& one o& "he ingedien"s, o +. occ(ence o& a "o1ic !ani&es"a"ion #i"hin "he pa"ien". 'so(ce) Co!piled *ec"(e No"es &o Pha!ace("ical Che!is"y +, '-(g .(ali"y Con"ol 1/01a!ples)1. 4able" pe&o!ance has been sho#n "o $ay &o 9e"oolac "o!e"ha!ine, depending (pon "he 9ind o& s"ach "ha" #as (sed. Cons"ach sho#ed a deceased disin"ega"ion "i!e and dissol("ion a"e as a &(nc"ion o& blending "i!e #heeas pegela"ini%ed s"ach sho#ed no s(ch dependency. 4he di@eence be"#een "hese "#o e1cipien"s #as a""ib("ed "o "he &o!a"ion o& d(gAcons"ach agglo!ea"es #i"h !agnesi(! s"eaa"e.'6e!ing"on 71s"0di"ion/7. Cas"o Bil and o"he f1ed oil sho(ld no" be gi$en #i"h san"onin o aspidi(! oleoesin as "he oil inceases "he sol(bili"y o& "he ac"i$e pinciple and "h(s incease"hei "o1ici"y.2o(ce) h""p)AA1is"so(ce.blogspo".co!A7+1>A>CApha!acy-inco!pa"ibili"y-"heape("ic.h"!lD!E1+. 612odii salicyla"is FFFF..FF ii o%Hydag. Chloid. Gi"is FF.. 1ii gG. &". p(l$. H1ii2ig. Bne e$ey + ho(s.4he sodi(! salicyla"e inceases "he sali$a"ing po#e o& calo!el. and "he dose o& "he la""e, consideing "he &e8(ency o& ad!inis"a"ion, is 8(es"ionable "ho(gh no" necessaily dangeo(s.h""p)AA1is"so(ce.blogspo".co!A7+1>A>CApha!acy-inco!pa"ibili"y-"heape("ic.h"!lD!E1